NCI Senior Leadership

Douglas R. Lowy, M.D.
NCI Acting Director, National Cancer Institute

James Doroshow, M.D.
Deputy Director, Clinical & Translational Research
Director, Division of Cancer Treatment & Diagnosis

Donna Siegle
Deputy Director for Management, Office of Management
Executive Officer

Dinah S. Singer, Ph.D.
Deputy Director, Scientific Strategy & Development
Brigitte C. Widemann, M.D.
Special Advisor to the Director for Childhood Cancer

Anne Lubenow
Chief of Staff

Oliver Bogler, Ph.D.
Director, Center for Cancer Training

Philip E. Castle, Ph.D., M.P.H.
Director, Division of Cancer Prevention

Stephen J. Chanock, M.D.
Director, Division of Cancer Epidemiology & Genetics

Henry P. Ciolino, Ph.D.
Director, Office of Cancer Centers
Suzanne Frisbie, Ph.D.
Director, Technology Transfer Center

Dan Gallahan, Ph.D.
Director, Division of Cancer Biology
Peter Garrett
Director, Office of Communications & Public Liaison

Katrina A. B. Goddard, Ph.D.
Director, Division of Cancer Control & Population Sciences

Satish Gopal, M.D., M.P.H.
Director, Center for Global Health



Anthony Kerlavage, Ph.D.
Director, Center for Biomedical Informatics & Information Technology
Kristin Komschlies, Ph.D.
Acting Director, NCI Frederick Office of Scientific Operations

Glenn Merlino, Ph.D.
Scientific Director for Basic Research, Center for Cancer Research

Tom Misteli, Ph.D.
Director, Center for Cancer Research

Diane Palmieri, Ph.D.
Director, Center for Research Strategy

Sheila Prindiville, M.D., M.P.H.
Director, Coordinating Center for Clinical Trials

Henry Rodriguez, Ph.D., M.S., M.B.A.
Director, Office of Cancer Clinical Proteomics Research

Sharon A. Savage, M.D.
Clinical Director, Division of Cancer Epidemiology & Genetics

Jeffrey Shilling
Chief Information Officer

Sanya A. Springfield, Ph.D.
Director, Center to Reduce Cancer Health Disparities

Louis M. Staudt, M.D., Ph.D.
Director, Center for Cancer Genomics

Michael Weingarten, M.A.
Director, Small Business Innovation Research & Small Business Technology Transfer Programs

Robert Yarchoan, M.D.
Director, Office of HIV & AIDS Malignancy